Compounding pharmacyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list Peak Performance Peptides with 1 warning letter. The most recent is a warning letter dated Aug 24, 2026: Warning letter: Unapproved new drug.
Drug approvals, 510(k) clearances, recalls and letters, 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Aug 24, 2026 | Warning letter: Unapproved new drugCDER | Warning letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.